Posted on 04 April 2011
Tags: big pharma, china, Daiichi Sankyo, hypertension, Pfizer
Pfizer has agreed to promote a hypertension drug from Daiichi Sankyo Pharma in China.
Read the full press release on the Pfizer/Daiichi Sankyo deal at Current Agreements
Click here to cancel reply.
Email (will not be published) (required)
Your website (optional)
© 2021 Wildwood Ventures Ltd.